Interferon-a (IFN-a) application versus tumor necrosis factor-a antagonism for ocular Behçet's disease: focusing more on IFN. [electronic resource]
- The Journal of rheumatology Aug 2005
- 1633; author reply 1634 p. digital
Publication Type: Comment; Comparative Study; Letter
0315-162X
Antibodies, Monoclonal--therapeutic use Antirheumatic Agents--therapeutic use Behcet Syndrome--complications Humans Immunologic Factors--therapeutic use Infliximab Interferon-alpha--therapeutic use Tumor Necrosis Factor-alpha--antagonists & inhibitors Uveitis--drug therapy